NurExone Biologic Inc.

News & Events

Press Releases

In The Media

1. NurExone Strengthens Path to Clinical Trials for ExoPTEN with New Manufacturing Process Validation

   GlobeNewswire JUN 4, 2025 4:04 PM EDT
   TORONTO and HAIFA, Israel, June 04, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (...
   READ ARTICLE

2. NurExone Announces Clinical Trial Plans for Acute Spinal Cord Injury Therapy at Annual Meeting of American Spinal Injury Association

   GlobeNewswire MAY 30, 2025 4:04 PM EDT
   TORONTO and HAIFA, Israel, May 30, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (O...
   READ ARTICLE

3. NurExone Biologic Inc. Announces First Quarter 2025 Financial Results and Provides Corporate Update

   GlobeNewswire MAY 27, 2025 8:59 AM EDT
   TORONTO and HAIFA, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX...
   READ ARTICLE

4. NurExone Advances Vision Restoration Strategy with Preclinical Data Presentation at the Association for Research in Vision and Ophthalmology (ARVO) 2025

   GlobeNewswire MAY 8, 2025 4:04 PM EDT
   TORONTO and HAIFA, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (O...
   READ ARTICLE

5. NurExone Expands European Engagement with Investor Events in Germany and Switzerland

   GlobeNewswire MAY 2, 2025 4:05 PM EDT
   TORONTO and HAIFA, Israel, May 02, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (O...
   READ ARTICLE

6. NurExone to Showcase Breakthrough in Facial Nerve Regeneration at ISEV 2025

   GlobeNewswire APR 24, 2025 4:15 PM EDT
   TORONTO and HAIFA, Israel, April 24, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) ...
   READ ARTICLE

7. NurExone Appoints Biotech Industry Leader - Jacob Licht to Lead U.S. Operations and Exo-Top Manufacturing Expansion and Completes Continuance into Ontario

   GlobeNewswire APR 22, 2025 4:05 PM EDT
   TORONTO and HAIFA, Israel, April 22, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) ...
   READ ARTICLE

8. NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Corporate Update

   GlobeNewswire APR 9, 2025 5:15 PM EDT
   TORONTO and HAIFA, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) ...
   READ ARTICLE

9. NurExone Biologic Announces U.S. Uplisting Intention and Closes C$2.3 Million Private Placement

   GlobeNewswire APR 4, 2025 9:16 AM EDT
   TORONTO and HAIFA, Israel, April 04, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: N...
   READ ARTICLE

10. ExoPTEN Preclinical Study Demonstrates Significant Potential for Enhancing Motor Function, Blood Flow, and Spinal Cord Injury Recovery

    GlobeNewswire MAR 14, 2025 4:03 PM EDT
    TORONTO and HAIFA, Israel, March 14, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) ...
    READ ARTICLE